100.01USD+0.83%Mkt Cap: 6.45B USDP/E: —Last update: 2026-05-26
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric p…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap6.45B USD
Enterprise Value6.02B USD
Revenue (TTM)74.06M USD
Gross Profit74.06M USD
Net Income (TTM)-130.15M USD
Revenue/Share1.155 USD
Last Price100.01 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees131
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-149.00
PEG—
EV/EBITDA-42.71
EV/Revenue81.31
P/S88.58
P/B10.00
EPS (TTM)-1.81
EPS (Forward)-0.68
52W Range
45.1488% of range107.84
52W High107.84 USD
52W Low45.14 USD
Profitability
Gross Margin100.00%
Oper. Margin-6.47%
EBITDA Margin-190.40%
Profit Margin-282.83%
ROE-21.17%
ROA-19.48%
Growth
Revenue Growth99.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF57.67M USD
CapEx (TTM)1.59M USD
FCF Margin-104.86%
FCF Yield-1.20%
Net Debt-538.01M USD
Net Debt/EBITDA3.82
Balance Sheet
Debt/Equity0.02
Current Ratio17.76
Quick Ratio17.51
Book Value/Sh10.21 USD
Cash/Share8.518 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)117.33 USD
Target Range100.00 USD – 137.00 USD
# Analysts12
Ownership
Shares Out.64.31M
Float52.49M
Insiders0.71%
Institutions125.27%
Short Interest
Short Ratio10.7d
Short % Float13.64%
Short % Out.11.73%
Shares Short7.54M
Short (prev mo.)8.63M
Technical
SMA 50101.17 (-1.1%)
SMA 20083.02 (+20.5%)
Beta1.88
S&P 52W Chg28.31%
Avg Vol (30d)575.29K
Avg Vol (10d)494.27K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—